Skip to main content

Table 1 Participant characteristics by SCS type

From: Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada

 

Type of SCS

p value

HR-embedded N (Col %)

CHC-embedded N (Col %)

Total

305 (43.5)

164 (23.4)

 

Age, median (IQR)

37 (30–44)

40.5 (34–49.5)

< 0.001

Gender

  

0.732

 Cisgender women

103 (34.0)

50 (30.5)

 

 Cisgender men

187 (61.7)

106 (64.6)

 

 Transgender or gender-diverse

13 (4.3)

8 (4.9)

 

Race/ethnicity

  

0.968

 Indigenous

98 (32.1)

53 (32.5)

 

 Racialized, non-indigenous

38 (12.5)

19 (11.7)

 

 White

169 (55.4)

91 (55.8)

 

Education

  

0.948

 High school or less

203 (66.8)

110 (67.1)

 

 Any post-secondary

101 (33.2)

54 (32.9)

 

Housing**

  

0.532

 Any unstable

260 (85.2)

134 (81.7)

 

 Stable

20 (6.6)

13 (7.9)

 

 Missing

25 (8.2)

17 (10.4)

 

Drug injected most often**

  

< 0.001

 Fentanyl

191 (62.6)

70 (42.7)

 

 Heroin

12 (3.9)

21 (12.8)

 

 Prescription opioids

9 (3.0)

21 (12.8)

 

 Crystal methamphetamine

61 (20.0)

22 (13.4)

 

 Cocaine or crack/rock cocaine

15 (4.9)

21 (12.8)

 

 Other

14 (4.6)

7 (4.3)

 

Injections per day (Mean, SD)**

4.9 (4.2)

4.8 (3.7)

0.716

Currently receiving medication for substance use

113 (37.2)

63 (38.7)

0.753

Frequency of any SCS use**

  

< 0.001

 Daily or more

151 (49.5)

42 (25.6)

 

 Once a week or more—less than daily

110 (36.1)

80 (48.8)

 

 Less than weekly

40 (13.1)

39 (23.8)

 
  1. Any unstable housing includes spending a night in the last six months in a place where people gather to use drugs, hotel/motel room, no fixed address, on the street, rooming or boarding house, shelter or hostel, or transitional housing
  2. HR harm reduction, CHC community health center, Col% column percent, IQR Interquartile range
  3. *0 missing age; 2 individuals missing gender; 1 individual was missing race/ethnicity; 1 individual missing education; 42 missing housing; 5 missing drug injected most often; 4 missing injections per day; 2 missing medication for substance use; 7 were missing frequency of any SCS use
  4. **Over the previous six months